Clinical Trials · NCT04936984
Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Radius Health, Inc.
- Enrollment
- 36
- Start date
- Nov 2020
- Locations
- 1 site, United States
- Primary endpoint
- Maximum observed concentration (Cmax)